EORTC-20855-LYMG

Phase III trial comparing CHVmP/VCR-BLM vs modified ProMACE/MOPP regimen for patients with stages II, III, IV lymphomas of intermediate and high grade malignancy
Trial StatusAll trial activities ended
DatesDate of activation: 15-Jan-86
Closed on : 10-Jan-91
Data management at EORTCFull
Phase3
Randomized trialYes
Type-
Targeted Sample size300
Number of steps1
Drug
Study Staff
Type of cancerNon Hodgkins Lymphoma
Participating GroupsEORTC Lymphoma Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT
@
Back to Protocol section